Pharmaceutical companies
Brand, medical, access and commercial teams, from affiliate to regional head office.
Healthcare market research · HEOR · Consulting
Healthcare intelligence that moves markets. Across the GCC, MENA and Africa.
Syndex gives pharmaceutical, biotech and medtech teams the evidence to size markets, launch with confidence, prove value to payers and grow share, in every therapy area, from a single study to a full regional programme.
60+Markets across GCC+, MENA and Africa
30+Therapy areas, from oncology to rare disease
24Specialist services across insight, evidence and strategy
360°Market, physician, payer and patient evidence
Every therapy area, including
OncologyImmuno-oncologyHaematologyHaemophiliaObesity & metabolicDiabetesEndocrinologyCardiologyRespiratoryImmunologyRheumatologyDermatologyGastroenterology & IBDHepatologyNephrologyNeurologyMultiple sclerosisPsychiatry & mental healthRare & orphan diseasesGene & cell therapyInfectious diseasesVaccinesOphthalmologyWomen’s health & fertilityUrologyPain & anaesthesiaCritical careTransplantationPaediatricsAestheticsMedical devices & diagnosticsConsumer health & OTC
Solutions
Everything you need to understand, enter and win a market
Three connected capabilities, one partner. Insight, evidence and strategy built on the same reliable data, so brand, medical, access and commercial teams all pull in one direction.
01
Market insights
Know your market better than anyone
Syndicated trackers and custom studies that show who prescribes what, where and why, with the account-level detail your teams need to act.
Discuss a studySyndicated trackers
Always-on therapy-area monitors showing uptake, share and account dynamics, wave after wave.
Account penetration studies
Hospital and account-level views of where your brand wins, and where it is missing.
HCP quantitative surveys
Robust samples of specialists and GPs, sized to answer your question with confidence.
Qualitative & in-depth interviews
Candid conversations with physicians, pharmacists and KOLs that explain the numbers.
Patient record forms & chart audits
Real treatment decisions, line by line, from real clinical practice.
Source of business
Exactly where new patients come from, and which competitor you are winning them from.
Brand health tracking
Awareness, trial, usage and advocacy, tracked against every key competitor.
Competitive intelligence
Competitor pipelines, launches and positioning, seen before they reach your market.
02
HEOR · Pharmacoeconomics · Access
Prove your value. Secure your access.
Payers and HTA bodies across the region want local evidence. We build it: models adapted to local costs and practice, real-world data from the markets that matter, and dossiers ready for submission.
Discuss an HEOR projectCost-effectiveness models
Local adaptations built on local costs, comparators and clinical practice.
Budget impact models
What adoption will cost each payer, year by year, in a model they can test themselves.
Burden of illness
The clinical and economic cost of the disease in each market, quantified.
Real-world evidence
Treatment patterns, outcomes and resource use from real clinical practice.
Value dossiers
Your global value story, localised for GCC, MENA and African payers.
HTA, formulary & tender support
Evidence packages ready for formulary, tender and reimbursement submissions.
Payer research
What payers, formulary committees and procurement bodies need to say yes.
Pricing strategy
Price corridors, tender dynamics and reference pricing, modelled before you launch.
03
Strategy & analytics
Turn evidence into growth
Forecasts, business cases and commercial strategy that stand up in front of regional and global leadership, delivered as datasets and dashboards your teams use every day.
Plan your next moveMarket sizing & forecasting
Patient-based models that tie every number back to epidemiology and real practice.
NPV business cases
Investment cases for in-licensing, launch and lifecycle decisions.
Launch excellence
Readiness assessments and launch trackers that flag issues while there is time to act.
Segmentation & targeting
HCP and account segments that focus your field force where it counts.
Go-to-market strategy
Positioning, channel and resourcing plans for each market and each stage.
Market entry & feasibility
Whether, where and how to enter, backed by local evidence.
Health planning advisory
Capacity, service and innovation planning for providers and health authorities.
Dashboards & data products
Validated datasets and live Power BI dashboards, ready on day one.
Who we work with
Built for everyone who shapes healthcare
From global pharma to local providers, our clients share one need: evidence they can act on.
Biotech & specialty
Emerging biopharma planning a first launch in the region.
MedTech & diagnostics
Adoption, procedure volumes and tender intelligence for devices and diagnostics.
Consumer health
OTC, supplements and pharmacy-channel insight.
Payers & insurers
Evidence to plan formularies, budgets and value-based contracts.
Hospitals & providers
Service-line planning, capacity and patient-flow analysis.
Governments & health authorities
Health planning, policy evidence and market assessments.
Investors & partners
Commercial due diligence and market entry for healthcare investments.
Expertise
Whatever your question, we find the answer
We work across every therapy area and every stage of the product lifecycle. These are the questions clients bring us most.
Pre-launch→Launch→Growth→Maturity→Loss of exclusivity
How big is my market, really?
Patient-based sizing that holds up from the country manager to global leadership.
Where is my share coming from, and going to?
Source-of-business and switching analysis that shows exactly where you win and lose.
Which accounts will make or break my launch?
Account-level mapping that puts your field force where it counts.
What will payers say yes to?
Pricing, HTA and pharmacoeconomic evidence that builds an undeniable value case.
What do physicians really think of my brand?
Candid HCP insight on perceptions, barriers and the unmet needs behind every prescription.
What is my competitor planning next?
Pipeline, launch and positioning intelligence before it reaches your market.
Is this market worth entering?
Feasibility studies and NPV business cases built on local reality, not assumptions.
Is my launch on track?
Launch trackers that show what is working, and what is not, while there is still time to act.
Have a different question? Tell us about it →
Coverage
One partner from the Gulf to the Cape
We run studies across more than 60 markets in three regions, working directly with physicians, pharmacists, payers and hospital decision-makers.
GCC & Gulf+
Our home region, with recurring trackers and custom studies in every GCC state, plus Iraq and Yemen.
UAESaudi ArabiaKuwaitQatarBahrainOmanIraqYemen
Levant & North Africa
Custom research, access and market assessments across the Levant and North Africa.
EgyptJordanLebanonSyriaPalestineMoroccoAlgeriaTunisiaLibya
Pan-African coverage
The whole continent, from North Africa to Sub-Saharan markets, scoped to your portfolio and priorities.
North AfricaWest AfricaEast AfricaCentral AfricaSouthern Africa
Headquarters: Ajman Free Zone, United Arab Emirates
Approach
How a Syndex study runs
01 · SCOPE
Define the question
We agree the business question, sample, KPIs and deliverables with your team before fieldwork starts.
02 · FIELD
Collect at the source
We work directly with healthcare professionals, payers and institutions in each market.
03 · VALIDATE
Check every figure
Multi-step quality control: completeness checks, outlier review and consistency across waves.
04 · DELIVER
Turn data into decisions
Clean datasets, dashboards and clear recommendations, delivered on the agreed timeline.
Why Syndex
Built for decisions, not decks
Every Syndex study is designed around the decision you need to make, with the depth, speed and accuracy that decision deserves.
01
Senior-led, brief to boardroom
A senior team scopes, runs and presents every study. No hand-offs, no diluted insight.
02
Direct line to decision-makers
We speak directly with physicians, pharmacists, payers and hospital leaders across 60+ markets.
03
Hard-to-reach is our home ground
Rare diseases, specialty care and frontier markets, where standard panels fall short.
04
Numbers you can stand behind
Every figure is validated at the source and cross-checked before it reaches your desk.
05
Fast, without cutting corners
Agile study design and rapid fieldwork, so insight lands while the decision is still open.
06
Ready to use on day one
Clean datasets, live Power BI dashboards and clear recommendations, not just slides.
Contact
Let’s talk about your next decision
Tell us about your market question and we will come back to you within one working day.
Syndex Research F.Z.C
Office C1-1F-SF13603, Ajman Free Zone C1 Building
Ajman, United Arab Emirates